ICD-10-CM Codes
C00-D49 Neoplasms
D3A-D3A Benign neuroendocrine tumors
D3A- Benign neuroendocrine tumors
2022 ICD-10-CM Diagnosis Code D3A.098

2022 ICD-10-CM Diagnosis Code D3A.098

Benign carcinoid tumors of other sites

2016

2017

2018

2019

2020

2021

2022

Billable/Specific Code

D3A.098 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
The 2022 edition of ICD-10-CM D3A.098 became effective on October 1, 2021.
This is the American ICD-10-CM version of D3A.098 - other international versions of ICD-10 D3A.098 may differ.

The following code(s) above D3A.098 contain annotation back-references

Annotation Back-References

In this context, annotation back-references refer to codes that contain:

Applicable To annotations, or
Code Also annotations, or
Code First annotations, or
Excludes1 annotations, or
Excludes2 annotations, or
Includes annotations, or
Note annotations, or
Use Additional annotations

that may be applicable to D3A.098:

C00-D49
2022 ICD-10-CM Range C00-D49
Neoplasms
Note
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
Neoplasms
D3A
ICD-10-CM Diagnosis Code D3A
Benign neuroendocrine tumors
Code Also
- any associated multiple endocrine neoplasia [MEN] syndromes (E31.2-)
Type 2 Excludes
- benign pancreatic islet cell tumors (D13.7)
Use Additional
- code to identify any associated endocrine syndrome, such as:
- carcinoid syndrome (E34.0)
Benign neuroendocrine tumors

ICD-10-CM D3A.098 is grouped within Diagnostic Related Group(s) (MS-DRG v39.0):

826 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures with mcc
827 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures with cc
828 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures without cc/mcc
829 Myeloproliferative disorders or poorly differentiated neoplasms with other procedures with cc/mcc
830 Myeloproliferative disorders or poorly differentiated neoplasms with other procedures without cc/mcc
843 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses with mcc
844 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses with cc
845 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses without cc/mcc

Convert D3A.098 to ICD-9-CM

Code History

2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
2017 (effective 10/1/2016): No change
2018 (effective 10/1/2017): No change
2019 (effective 10/1/2018): No change
2020 (effective 10/1/2019): No change
2021 (effective 10/1/2020): No change
2022 (effective 10/1/2021): No change

Diagnosis Index entries containing back-references to D3A.098:

Tumor - see also Neoplasm, unspecified behavior, by site
- carcinoid D3A.00
  ICD-10-CM Diagnosis Code D3A.00
  Benign carcinoid tumor of unspecified site
  2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code
  Applicable To
  Carcinoid tumor NOS
  - benign D3A.00
    ICD-10-CM Diagnosis Code D3A.00
    Benign carcinoid tumor of unspecified site
    2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code
    Applicable To
    Carcinoid tumor NOS
    - specified NEC D3A.098

ICD-10-CM Codes Adjacent To D3A.098

D3A.026 Benign carcinoid tumor of the rectum

D3A.029 Benign carcinoid tumor of the large intestine, unspecified portion

D3A.09 Benign carcinoid tumors of other sites

D3A.090 Benign carcinoid tumor of the bronchus and lung

D3A.091 Benign carcinoid tumor of the thymus

D3A.092 Benign carcinoid tumor of the stomach

D3A.093 Benign carcinoid tumor of the kidney

D3A.094 Benign carcinoid tumor of the foregut, unspecified

D3A.095 Benign carcinoid tumor of the midgut, unspecified

D3A.096 Benign carcinoid tumor of the hindgut, unspecified

D3A.098 Benign carcinoid tumors of other sites

D3A.8 Other benign neuroendocrine tumors

D37 Neoplasm of uncertain behavior of oral cavity and digestive organs

D37.0 Neoplasm of uncertain behavior of lip, oral cavity and pharynx

D37.01 Neoplasm of uncertain behavior of lip

D37.02 Neoplasm of uncertain behavior of tongue

D37.03 Neoplasm of uncertain behavior of the major salivary glands

D37.030 Neoplasm of uncertain behavior of the parotid salivary glands

D37.031 Neoplasm of uncertain behavior of the sublingual salivary glands

D37.032 Neoplasm of uncertain behavior of the submandibular salivary glands

D37.039 …… unspecified

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

2022 ICD-10-CM Diagnosis Code D3A.098

Benign carcinoid tumors of other sites

Neoplasms

Benign neuroendocrine tumors

Benign carcinoid tumor of unspecified site

Benign carcinoid tumor of unspecified site